Your browser doesn't support javascript.
loading
Development of a Manufacturing Process toward the Convergent Synthesis of the COVID-19 Antiviral Ensitrelvir.
Kawajiri, Takahiro; Kijima, Akihito; Iimuro, Atsuhiro; Ohashi, Eisaku; Yamakawa, Katsuya; Agura, Kazushi; Masuda, Kengo; Kouki, Kensuke; Kasamatsu, Koji; Yanagisawa, Shuichi; Nakashima, Sho; Shibahara, Setsuya; Toyota, Takashi; Higuchi, Takafumi; Suto, Takahiro; Oohara, Tadashi; Maki, Toshikatsu; Sahara, Naoto; Fukui, Nobuaki; Wakamori, Hisayuki; Ikemoto, Hidaka; Murakami, Hiroaki; Ando, Hiroyasu; Hosoya, Masahiro; Sato, Mizuki; Suzuki, Yusuke; Nakagawa, Yuta; Unoh, Yuto; Hirano, Yoichi; Nagasawa, Yoshitomo; Goda, Satoshi; Ohara, Takafumi; Tsuritani, Takayuki.
Afiliação
  • Kawajiri T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Kijima A; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Iimuro A; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Ohashi E; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Yamakawa K; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Agura K; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Masuda K; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Kouki K; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Kasamatsu K; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Yanagisawa S; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Nakashima S; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Shibahara S; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Toyota T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Higuchi T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Suto T; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Oohara T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Maki T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Sahara N; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Fukui N; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Wakamori H; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Ikemoto H; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Murakami H; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Ando H; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Hosoya M; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Sato M; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Suzuki Y; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Nakagawa Y; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Unoh Y; Laboratory for Medicinal Chemistry Research, Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-Chome, Toyonaka, Osaka 561-0825, Japan.
  • Hirano Y; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Nagasawa Y; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Goda S; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Ohara T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
  • Tsuritani T; API R&D Laboratory, Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.
ACS Cent Sci ; 9(4): 836-843, 2023 Apr 26.
Article em En | MEDLINE | ID: mdl-37122445

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: ACS Cent Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: ACS Cent Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão